PM — Philip Morris International Inc.

Summary of Philip Morris International (PM) Q2 2026 Earnings Call

1. Key Financial Results and Metrics

• Organic Growth: Q2 net revenue grew by +8% and operating income by +11%. Adjusted diluted EPS reached $2.20, reflecting a +15% increase year-over-year.
• Revenue: Quarterly net revenues exceeded $11 billion for the first time, with organic net revenue growth of +7.6%.
• Profitability: Adjusted gross profit increased by +8.7% organically, driven by pricing and favorable smoke-free product mix.
• Volume Growth: Total shipment volumes rose by +2.5% in Q2, with smoke-free products growing by +7.5% and combustible products by +1.1%.

2. Strategic Updates and Business Highlights

• Smoke-Free Products: Continued strong performance in IQOS, with adjusted in-market sales volume up +5% despite headwinds in Japan and Poland. The multi-category approach is gaining traction, particularly with ZYN and VEEV.
• U.S. Market: Significant sequential improvement in net revenues and gross profit, with ZYN shipments increasing by +2% to 2.9 billion pouches. New product variants, including ZYN Ultra, are being introduced to enhance market presence.
• Cost Management: PMI achieved over $300 million in gross cost savings in H1, on track to meet a $2 billion target for 2024-2026.

3. Forward Guidance and Outlook

• Full-Year Targets: PMI maintains its guidance for organic net revenue growth of +5% to +7% and organic operating income growth of +7% to +9%. Adjusted diluted EPS is forecasted to be between $8.26 and $8.41, reflecting a currency tailwind.
• Q3 Expectations: Anticipates HTU shipment volume of around 41 billion units and mid-single-digit organic top-line growth, with adjusted diluted EPS projected at $2.20 to $2.25.

4. Challenges and Points of Concern

• Market Dynamics: Despite strong performance, PMI faces challenges in Japan due to recent excise tax increases and competitive pressures. The company noted a slowdown in category growth and potential volatility in H2.
• Regulatory Environment: Ongoing regulatory changes, particularly in the U.S. and EU, could impact product positioning and market dynamics.
• Cigarette Volume Decline: While cigarette volumes are expected to decline by 2%-3% for the full year, this is an improvement from previous forecasts.

5. Notable Q&A Insights

• Investment Strategy: Management confirmed that increased investments in the U.S. are aimed at supporting ZYN's market position and preparing for the launch of IQOS ILUMA.
• ZYN Ultra Feedback: Early feedback on ZYN Ultra has been positive, with expectations for it to enhance the brand's competitive positioning.
• Japan Market Insights: Management acknowledged the competitive landscape in Japan, noting that while IQOS maintained its market share, the overall category is experiencing slower growth due to significant price increases.

Overall, PMI reported strong financial performance in Q2 2026, driven by robust growth in smoke-free products and effective cost management, while also navigating challenges in specific markets and regulatory environments. The company remains optimistic about its growth trajectory and strategic investments.